Mindray Announced Shareholder Resolutions post Annual General Meeting 2012 PR Newswire SHENZHEN, China, Dec. 31, 2012 SHENZHEN, China, Dec. 31, 2012 /PRNewswire-FirstCall/ -- Mindray Medical International Limited ("Mindray", NYSE: MR), a leading developer, manufacturer and marketer of medical devices worldwide, today announced shareholder resolutions adopted at its annual general meeting of shareholders held in Hong Kong on December 28,2012. At the meeting, Mindray shareholders approved the re-election of incumbent directors Xu Hang, Ronald Ede and Chen Qingtai, each to serve a three-year term. In addition, Mindray shareholders ratified the appointment of PricewaterhouseCoopers as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2012. About Mindray We are a leading developer, manufacturer and marketer of medical devices worldwide. We maintain our global headquarters inShenzhen, China, U.S. headquarters inMahwah, New Jerseyand multiple sales offices in major international markets. From our main manufacturing and engineering base inChina, we supply through our worldwide distribution network a broad range of products across three primary business segments, namely patient monitoring and life support, in-vitro diagnostic, and medical imaging systems. For more information, please visithttp://ir.mindray.com. For investor and media inquiries please contact: In the U.S: Hoki Luk Western Bridge, LLC Tel: +1-646-808-9150 Email: email@example.com In China: Cathy Gao Mindray Medical International Limited Tel: +86-755-8188-8023 Email: firstname.lastname@example.org SOURCE Mindray Medical International Limited Website: http://ir.mindray.com
Mindray Announced Shareholder Resolutions post Annual General Meeting 2012
Press spacebar to pause and continue. Press esc to stop.